US Patent Issued to HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT on Sept. 9 for "Milk derived extracellular vesicles for use in treating inflammatory bowel disease" (Israeli Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,190, issued on Sept. 9, was assigned to HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD. (Jerusalem).

"Milk derived extracellular vesicles for use in treating inflammatory bowel disease" was invented by Shimon Reif (Jerusalem) and Regina Golan-Gerstl (Maale Michmash, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to compositions containing exosomes isolated from milk and methods and uses thereof for treating inflammatory bowel disease (IBD) and conditions related thereto. In particular, disclosed are exosomes derived from milk and enteral formulations supplemented therewith for use in treating IBD. The c...